SCHEMBL4665992

SCHEMBL4665992

CCN(CC)CCCn1cc(-c2cc(Nc3ccc(N(OC=O)S(=O)(=O)c4ccc(F)cc4F)cc3)ncn2)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C19 P33261 3/20 0.35
USP2 O75604 2/20 0.35
ALDH1A1 P00352 2/20 0.35
ALOX15 P16050 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
LMNA P02545 1/20 0.35
CDK9 P50750 6/20 0.35
CYP3A4 P08684 2/20 0.34
MAPK1 P28482 2/20 0.34
HPGD P15428 1/20 0.34
EGFR P00533 5/20 0.34
ABCB1 P08183 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
PRKCA P17252 3/20 0.33
HTR6 P50406 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4667477 0.94 EGFR (0.35) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4666179 0.91 PRKCA (0.35) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4667452 0.89 PRKCB (0.40) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4667437 0.86 KMT2A (0.37) CDK9EGFRPRKCAMEN1KMT2A
Formic Acid SCHEMBL4665989 0.86 PRKCA (0.36) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4665777 0.83 EGFR (0.40) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4666099 0.82 PRKCB (0.41) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
SCHEMBL4663921 0.81 EGFR (0.39) CYP1A2CYP2D6CYP2C19USP2ALDH1A1
Formic Acid SCHEMBL4667475 0.80 HTR6 (0.38) CYP1A2CYP2D6CYP2C19CDK9CYP3A4
SCHEMBL4665715 0.79 EGFR (0.43) CYP1A2CYP2D6CYP2C19USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors ALTANA PHARMA AG (DE) 2008-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080242681-A1 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors MAP3K19, MAP3K6, MAP3K20 CYP1A2 1215/4885CYP2D6 646/4885CYP2C19 961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.